We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.

Search Results

Showing 1-20 of 2,851 results
  1. Growth Hormone and Prolactin Co-secreting Pituitary Adenoma: a Case Report and Review of Literature

    Co-secreting growth hormone and prolactin pituitary adenomas, which comprise a considerable portion of all growth hormone-secreting adenomas, can be...

    Isabella L. Pecorari, Andre E. Boyke, ... Vijay Agarwal in SN Comprehensive Clinical Medicine
    Article 16 July 2022
  2. Global changes in chromatin accessibility and transcription in growth hormone-secreting pituitary adenoma

    Purpose

    Growth hormone-secreting pituitary adenoma (GHPA) is an insidious disease with persistent hypersecretion of growth hormone and insulin-like...

    Meng Wang, Chenxing Ji, ... Zhao Ye in Endocrine
    Article Open access 10 August 2022
  3. Giant growth hormone-secreting pituitary adenomas from the endocrinologist’s perspective

    Objectives

    Since giant (≥40 mm) GH-secreting pituitary adenomas are rarely encountered, data on their characteristics and treatment outcomes are...

    Bahadir Koylu, Busra Firlatan, ... Tomris Erbas in Endocrine
    Article 01 November 2022
  4. Clinical characteristics and therapeutic outcomes of acromegalic patients with giant growth hormone-secreting pituitary adenomas: a single-center study of 67 cases

    Purpose

    Acromegalic patients with giant growth hormone-secreting pituitary adenomas (GHPAs) (≥ 40 mm) are relatively rare, and their clinical...

    Mei** Chen, Lian Duan, ... Huijuan Zhu in Pituitary
    Article 17 October 2023
  5. Vascular anomalies in patients with growth hormone-secreting pituitary adenomas: illustrative case report and systematic review of the literature

    Purpose

    Endonasal resection is the first-line treatment for patients harboring growth hormone (GH)-secreting pituitary adenomas. The complexity of the...

    Dorothee Cäcilia Spille, Elena Vorona, ... Eric Suero-Molina in Pituitary
    Article Open access 12 December 2022
  6. Cost-effectiveness of direct surgery versus preoperative octreotide therapy for growth-hormone secreting pituitary adenomas

    Purpose

    The objective of this study was to compare the cost-effectiveness of preoperative octreotide therapy followed by surgery versus the standard...

    Lisa Caulley, Eline Krijkamp, ... Myriam G. M. Hunink in Pituitary
    Article Open access 27 August 2022
  7. Pituitary adenoma or neuroendocrine tumour: the need for an integrated prognostic classification

    In the 2022 fifth edition of the WHO Classification of Endocrine Tumours and of Central Nervous System Tumours, pituitary adenomas are reclassified...

    Ken K. Y. Ho, Ursula B. Kaiser, ... Shlomo Melmed in Nature Reviews Endocrinology
    Article 17 August 2023
  8. Current status of artificial intelligence technologies in pituitary adenoma surgery: a sco** review

    Purpose

    Pituitary adenoma surgery is a complex procedure due to critical adjacent neurovascular structures, variations in size and extensions of the...

    Seyed Farzad Maroufi, Yücel Doğruel, ... Paolo Palmisciano in Pituitary
    Article 06 January 2024
  9. Antiplatelet and anticoagulation therapy and the risk of pituitary apoplexy in pituitary adenoma patients

    Purpose

    Pituitary apoplexy can be a life threatening and vision compromising event. Antiplatelet and anticoagulation use has been reported as a...

    Bronson Ciavarra, Timothy McIntyre, ... Spiros L. Blackburn in Pituitary
    Article 28 April 2023
  10. Imaging of pituitary tumors: an update with the 5th WHO Classifications—part 1. Pituitary neuroendocrine tumor (PitNET)/pituitary adenoma

    The pituitary gland is the body’s master gland of the endocrine glands. Although it is a small organ, many types of tumors can develop within it. The...

    Taro Tsukamoto, Yukio Miki in Japanese Journal of Radiology
    Article Open access 24 February 2023
  11. Celastrol Induces Apoptosis and Autophagy via the AKT/mTOR Signaling Pathway in the Pituitary ACTH-secreting Adenoma Cells

    Objective

    Pituitary adrenocorticotropic hormone (ACTH)-secreting adenoma is a relatively intractable endocrine adenoma that can cause a range of...

    Zhi Cai, Bin Qian, ... Ting Lei in Current Medical Science
    Article 13 April 2022
  12. Clinical characteristics and outcomes of patients with TSH-secreting pituitary adenoma and Graves’ disease - a case report and systematic review

    Background

    Coexistence of TSH-secreting pituitary adenoma (TSHoma) and Graves’ disease (GD) is rare and complicates the management decision.

    ...
    Adeel Ahmad Khan, Shahd I. Ibrahim, ... Zeinab Dabbous in Thyroid Research
    Article Open access 05 February 2024
  13. Reported baseline variables in transsphenoidal surgery for pituitary adenoma over a 30 year period: a systematic review

    Purpose

    Heterogeneous reporting in baseline variables in patients undergoing transsphenoidal resection of pituitary adenoma precludes meaningful...

    Hugo Layard Horsfall, Ryan T. S. Loh, ... Angelos G. Kolias in Pituitary
    Article Open access 16 October 2023
  14. Ectopic invasive ACTH-secreting pituitary adenoma mimicking chordoma: a case report and literature review

    Background

    Ectopic pituitary adenoma (EPA) is defined as a special type of pituitary adenoma that originates outside of the sellar region, is extra-...

    Yan Li, Jian-Guo Zhu, ... Ji-Hong Tian in BMC Neurology
    Article Open access 23 February 2023
  15. Diagnosis and management of prolactin-secreting pituitary adenomas: a Pituitary Society international Consensus Statement

    This Consensus Statement from an international, multidisciplinary workshop sponsored by the Pituitary Society offers evidence-based graded consensus...

    Stephan Petersenn, Maria Fleseriu, ... Shlomo Melmed in Nature Reviews Endocrinology
    Article 05 September 2023
  16. Clinical characteristics and treatment strategies for pituitary adenoma associated with intracranial aneurysm

    Background

    This study aimed to investigate clinical features and treatment strategies for intracranial aneurysm (IA) associated with pituitary adenoma...

    Zheng Huang, Zeng Yang, ... Zhenyan Li in Chinese Neurosurgical Journal
    Article Open access 04 June 2024
  17. High prevalence of morphometric vertebral fractures opportunistically detected on thoracic radiograms in patients with non-functioning pituitary adenoma

    Purpose

    Vertebral fractures (VFs), the hallmark of skeletal fragility, have been reported as an emerging complication in patients with pituitary...

    Stefano Frara, Meliha Melin Uygur, ... Andrea Giustina in Pituitary
    Article 27 May 2024
  18. Validation of the anterior skull base questionnaire 35 in endoscopic pituitary adenoma surgery

    Patient quality of life (QOL) is an important metric of surgical success. To guide therapeutic advances in pituitary adenoma surgery, a validated,...

    Mendel Castle-Kirszbaum, Yi Yuen Wang, ... Tony Goldschlager in Neurosurgical Review
    Article 08 December 2022
  19. Concurrent mutations of germline GPR101 and somatic USP8 in a pediatric giant pituitary ACTH adenoma: a case report

    Background

    Cushing’s disease (CD) is rare in pediatric patients. It is characterized by elevated plasma adrenocorticotropic hormone (ACTH) from...

    Xu-dong Bao, Lin Lu, ... Zhao-lin Lu in BMC Endocrine Disorders
    Article Open access 06 June 2022
  20. Improvement of metabolic syndrome and its components in patients who underwent transsphenoidal resection for pituitary adenoma

    Background

    Pituitary adenomas (PA) are neoplasms of pituitary adenohypophyseal cell lineage, which are the third most common cause of brain tumors...

    A. P. Cortés-Contreras, A. Salazar-Pigeon, ... J. D. Carrillo-Ruiz in Acta Neurochirurgica
    Article 16 February 2024
Did you find what you were looking for? Share feedback.